Active — Not RecruitingNot Applicable

Proactive Prescription-based Fluid Management vs Usual Care in Critically Ill Patients on Kidney Replacement Therapy

Canada150 participantsStarted 2023-04-03

Plain-language summary

A pilot randomized clinical trial comparing a protocol-based fluid management strategy to usual care in critically ill patients receiving kidney replacement therapy. The fluid management protocol is intended to achieve neutral or negative daily fluid balance by both preventing and treating fluid accumulation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age ≥ 18 years
✓. Admitted to the ICU
✓. AKI during current hospitalization defined by the Kidney Disease: Improving Global Outcomes (KDIGO) criteria(1) as any of the following: Increase in serum creatinine by 27 µmol/L or more within any 48-hour window, or an increase in serum creatinine to 1.5 times baseline or more within the last 7 days, or a urine output less than 0.5 mL/kg/h for 6 hours.
✓. Planned initiation of KRT within the following 12 hours or the receipt of KRT for AKI for ≤48 hours

Exclusion criteria

✕. Lack of commitment to maintain kidney, pharmacologic or respiratory support at the time of screening, or probable transition to comfort care within 48 hours according to the treating physician
✕. Probable discharge from the ICU within the next 48 hours according to treating physician
✕. Severe burn injury (\>10% of body surface area)
✕. Severe abnormality in serum sodium (\>155 or \<120 mmol/L)
✕. Important ongoing fluid losses are present and/or are expected to require continued maintenance IV fluids uring the next 48 hours
✕. The clinical care team believes that the proposed intervention is inappropriate.

What they're measuring

Cumulative fluid balance

Timeframe: From randomization to the end of day 5

Trial details

NCT IDNCT05473143

SponsorCentre hospitalier de l'Université de Montréal (CHUM)

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-01

View on ClinicalTrials.gov More Acute Kidney Injury trials